Filip Krag Knop

Filip Krag Knop

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


Publication year:
All
11 - 19 out of 19Page size: 10
  1. 2013
  2. Published

    Psoriasis er associeret med type 2-diabetes

    Gyldenl�ve, M., Knop, Filip Krag, Vilsb�ll, T., Zachariae, Claus & Skov, Lone, 4 Mar 2013, In: Ugeskrift for Laeger. 175, 10, p. 652-4 3 p., 652.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients

    Sonne, D. P., Hare, K. J., Martens, P., Rehfeld, Jens Frederik, Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, 15 Feb 2013, In: American Journal of Physiology: Gastrointestinal and Liver Physiology. 304, 4, p. G413-9 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus

    Bonde, L., Vilsbøll, Tina, Nielsen, T., Bagger, J. I., Svare, J. A., Holst, Jens Juul, Larsen, S. & Knop, Filip Krag, 13 Feb 2013, In: Diabetes, Obesity and Metabolism. 15, 8, p. 713-720 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Increased expression of glucagon-like peptide-1 receptors in psoriasis plaques

    Faurschou, A., Pedersen, Jens, Gyldenløve, M., Poulsen, Steen Seier, Holst, Jens Juul, Thyssen, Jacob Pontoppidan, Zachariae, Claus, Vilsbøll, Tina, Skov, Lone & Knop, Filip Krag, Feb 2013, In: Experimental Dermatology. 22, 2, p. 150-2 3 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: protocol for systematic review and meta-analysis of clinical studies

    Rohde, U., Hedbäck, N., Gluud, Lise Lotte, Vilsbøll, T. & Knop, Filip Krag, 2013, In: B M J Open. 3, 9, p. 1-5 e003417.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations

    Jespersen, M. J., Knop, Filip Krag & Christensen, Mikkel Bring, 2013, In: Expert Opinion on Drug Metabolism & Toxicology. 9, 1, p. 17-29 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes

    Mari, A., Bagger, J. I., Ferrannini, E., Holst, Jens Juul, Knop, Filip Krag & Vilsbøll, T., 2013, In: PLOS ONE. 8, 9, p. e73154

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Preserved postprandial GLP-1 and GIP responses in patients with maturity onset diabetes of the young

    Bagger, J. I., Ostoft, S. H., Hansen, T., Pedersen, O., Holst, Jens Juul, Knop, Filip Krag & Vilsboll, T., 2013, In: Diabetologia. 56, p. S152-S152

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    The effect of a glucagon-like peptide-1 receptor agonist on glucose tolerance in women with previous gestational diabetes mellitus: protocol for an investigator-initiated, randomised, placebo-controlled, double-blinded, parallel intervention trial

    Foghsgaard, S., Vedtofte, L., Mathiesen, Elisabeth, Svare, J. A., Gluud, Lise Lotte, Holst, Jens Juul, Damm, Peter, Knop, Filip Krag & Vilsbøll, T., 2013, In: B M J Open. 3, 10, p. 1-8 9 p., e003834.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 Next

ID: 40100368